CSF HIV RNA Escape in Opsoclonus-Myoclonus-Ataxia Syndrome: Case Report and Review of the Literature.

In our case the reintroduction of dolutegravir improved the control of virus CNS infection as demonstrated on following CSF samples at 2 and 4 months ( Figure 2 ) with concomitant highly significant improvement in her clinical evolution.

also in 132,142 other papers